Search clinical trials for: SGN-35T
Total 1483 results
-
M.D. Anderson Cancer CenterTakedaWithdrawnAnaplastic Large Cell Lymphoma | Classical Hodgkin Lymphoma | Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic | CD30+ Peripheral T-cell Lymphoma
-
Seagen Inc.TerminatedAcute Myeloid LeukemiaUnited States
-
Seagen Inc.CompletedBurkitt Lymphoma | Precursor B-cell Lymphoblastic Leukemia-LymphomaUnited States
-
Seagen Inc.CompletedLymphoma, Non-Hodgkin | Carcinoma, Renal CellUnited States
-
Seagen Inc.Terminated
-
Seagen Inc.TerminatedNon-Hodgkin Lymphoma | Diffuse Large B-cell Lymphoma | DLBCL | Grade 3 Follicular LymphomaUnited States
-
Seagen Inc.CompletedRenal Cell Carcinoma | Diffuse, Large B-Cell, Lymphoma | Mantle-Cell Lymphoma | Follicular Lymphoma, Grade 3United States
-
Seagen Inc.CompletedLymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Burkitt Lymphoma | Lymphoma, Mantle-Cell | Precursor B-cell Lymphoblastic Leukemia-LymphomaUnited States
-
M.D. Anderson Cancer CenterSeagen Inc.Active, not recruitingLymphoma | Mycosis Fungoides | Lymphoma, Primary Cutaneous Anaplastic Large Cell | CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma | Lymphomatoid Papulosis | Skin Lymphoma | Cutaneous Lymphomas | Hematologic DisorderUnited States
-
TakedaActive, not recruiting
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedCervical Cancer | Precancerous ConditionUnited States
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed or Refractory Hodgkin Lymphoma | Relapsed or Refractory Anaplastic Large-cell LymphomaUnited States, France, United Kingdom, Germany, Spain, Netherlands, Italy, Mexico
-
M.D. Anderson Cancer CenterSeagen Inc.Recruiting
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingLymphomaBelgium, Spain, Czechia, Hungary, Croatia, Portugal, Turkey, Poland, United Kingdom, Romania
-
Seagen Inc.TerminatedHodgkin Lymphoma | Anaplastic Large Cell Lymphoma | Peripheral T Cell LymphomaUnited States
-
Seagen Inc.CompletedLarge Cell LymphomaUnited States
-
Seagen Inc.CompletedAcute Myeloid Leukemia | Solid Tumors | Acute Lymphoid Leukemia | Anemia, Refractory, With Excess of BlastsUnited States
-
Seagen Inc.RecruitingCarcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Squamous Cell Carcinoma of the Head and Neck | Pancreatic Ductal AdenocarcinomaUnited States
-
National Cancer Institute (NCI)SuspendedRecurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin LymphomaUnited States
-
Seagen Inc.CompletedLymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Lymphoma, T-CellUnited States, Canada
-
University of WashingtonNational Cancer Institute (NCI); Seagen Inc.Active, not recruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin LymphomaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingClassic Hodgkin Lymphoma | Ann Arbor Stage IB Hodgkin Lymphoma | Ann Arbor Stage II Hodgkin Lymphoma | Ann Arbor Stage IIA Hodgkin Lymphoma | Ann Arbor Stage IIB Hodgkin Lymphoma | Ann Arbor Stage I Hodgkin Lymphoma | Ann Arbor Stage IA Hodgkin LymphomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Genentech, Inc.TerminatedLymphomaUnited States
-
Seagen Inc.CompletedAcute Myeloid Leukemia | Acute Myelogenous Leukemia | Acute Promyelocytic LeukemiaUnited States
-
AllerganCompletedMeibomian Gland DysfunctionUnited States
-
Genentech, Inc.Seagen Inc.Completed
-
Northwestern UniversitySeagen Inc.; Robert H. Lurie Cancer CenterUnknownStage III Adult Hodgkin Lymphoma | Stage IV Adult Hodgkin Lymphoma | Stage II Adult Hodgkin Lymphoma | Adult Lymphocyte Depletion Hodgkin Lymphoma | Adult Lymphocyte Predominant Hodgkin Lymphoma | Adult Mixed Cellularity Hodgkin Lymphoma | Adult Nodular Sclerosis Hodgkin LymphomaUnited States
-
Seagen Inc.Bristol-Myers SquibbCompletedHodgkin LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterMethylGene Inc.CompletedHodgkin LymphomaUnited States
-
Daniel Zimpfer, MDTerminatedThrombosis | BleedingAustria
-
H. Lee Moffitt Cancer Center and Research InstituteSeagen Inc.Withdrawn
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingClassic Hodgkin Lymphoma | Lymphocyte-Rich Classic Hodgkin Lymphoma | Ann Arbor Stage IB Hodgkin Lymphoma | Ann Arbor Stage II Hodgkin Lymphoma | Ann Arbor Stage IIA Hodgkin Lymphoma | Ann Arbor Stage IIB Hodgkin Lymphoma | Ann Arbor Stage I Hodgkin Lymphoma | Ann Arbor Stage I Mixed Cellularity... and other conditionsUnited States
-
AllerganCompletedErythema | RosaceaUnited States
-
Seagen Inc.CompletedHodgkin DiseaseUnited States
-
University of Southern CaliforniaCompletedParkinson DiseaseUnited States
-
AllerganCompleted
-
AllerganCompletedHealthy VolunteersUnited States
-
RegeneRx Biopharmaceuticals, Inc.WithdrawnST Elevation Myocardial Infarction | Acute Myocardial Infarction | STEMI
-
AllerganCompletedPresbyopiaUnited States
-
Supernus Pharmaceuticals, Inc.CompletedAttention-Deficit/Hyperactivity Disorder (ADHD)United States
-
AllerganCompletedUrinary Bladder, OveractiveFrance, United States, Netherlands
-
Fondazione Italiana Linfomi ONLUSCompleted
-
Xuanwu Hospital, BeijingPeking University; Beijing Tiantan Hospital; Qilu Hospital of Shandong University and other collaboratorsRecruitingEpilepsy, Drug ResistantChina
-
Marc-André Maheu-CadotteCompletedHeart Failure | MotivationCanada
-
AllerganTerminatedNeuralgia, PostherpeticUnited States, Austria, Poland, Germany
-
AllerganCompletedErythema | RosaceaUnited States
-
AllerganCompleted
-
AllerganCompletedNeuralgia, PostherpeticPoland, United States, Czech Republic, Germany
-
Lawson Health Research InstituteSeagen Inc.CompletedDiffuse Cutaneous Systemic SclerosisCanada
-
Jason Robert GotlibSeagen Inc.CompletedSystemic Mastocytosis | Mast Cell Leukemia | Aggressive Systemic MastocytosisUnited States